WeSearch

STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end

John Wilkerson· ·3 min read · 0 reactions · 0 comments · 7 views
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end

After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.

Original article
STAT · John Wilkerson
Read full at STAT →
Opening excerpt (first ~120 words) tap to expand

STAT PlusPolitics Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end Weight loss drugs will be available to adults 65 and older in Medicare for the first time next month Manage alerts for this article Email this article Share this article Adbe By John WilkersonJune 15, 2026 Washington Correspondent John Wilkerson[email protected]John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Weight loss drugs will be available to adults 65 and older in Medicare for the first time next month, thanks to a government program that’s supposed to be temporary. It may be difficult to end it.

Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT